U.S. markets open in 3 hours 53 minutes
  • S&P Futures

    3,792.25
    -24.50 (-0.64%)
     
  • Dow Futures

    31,079.00
    -157.00 (-0.50%)
     
  • Nasdaq Futures

    12,598.00
    -83.75 (-0.66%)
     
  • Russell 2000 Futures

    2,181.20
    -24.60 (-1.12%)
     
  • Crude Oil

    60.66
    -0.62 (-1.01%)
     
  • Gold

    1,708.30
    -7.50 (-0.44%)
     
  • Silver

    25.91
    -0.48 (-1.81%)
     
  • EUR/USD

    1.2044
    -0.0023 (-0.19%)
     
  • 10-Yr Bond

    1.4700
    0.0000 (0.00%)
     
  • Vix

    27.39
    +3.29 (+13.65%)
     
  • GBP/USD

    1.3932
    -0.0020 (-0.15%)
     
  • USD/JPY

    107.3350
    +0.3330 (+0.31%)
     
  • BTC-USD

    49,157.32
    -2,053.19 (-4.01%)
     
  • CMC Crypto 200

    986.36
    -0.85 (-0.09%)
     
  • FTSE 100

    6,583.26
    -92.21 (-1.38%)
     
  • Nikkei 225

    28,930.11
    -628.99 (-2.13%)
     

SHAREHOLDER ALERT: BIIB NAK QS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / January 6, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Biogen Inc. (NASDAQ:BIIB)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/biogen-inc-loss-submission-form?prid=11987&wire=1
Lead Plaintiff Deadline: January 12, 2021
Class Period: October 22, 2019 - November 6, 2019

Allegations against BIIB include that: (1) the larger dataset did not provide necessary data regarding aducanumab's effectiveness; (2) the EMERGE study did not and would not provide necessary data regarding the effectiveness of aducanumab, Biogen's investigational human monoclonal antibody studied for the treatment of early Alzheimer's disease; (3) the PRIME study did not and would not provide necessary data regarding aducanumab's effectiveness; (4) the data provided by the Company to the U.S. Food and Drug Administration's Peripheral and Central Nervous System Drugs Advisory Committee did not support finding efficacy of aducanumab; and (5) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Northern Dynasty Minerals Ltd. (NYSE:NAK)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/northern-dynasty-minerals-ltd-loss-submission-form?prid=11987&wire=1
Lead Plaintiff Deadline: February 2, 2021
Class Period: December 21, 2017 - November 25, 2020

Allegations against NAK include that: (1) the Company's Pebble Project was contrary to Clean Water Act guidelines and to the public interest; (2) the Company planned that the Pebble Project would be larger in duration and scope than conveyed to the public; (3) as a result, the Company's permit applications for the Pebble Project would be denied by the U.S. Army Corps of Engineers; and (4) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.

QuantumScape Corporation f/k/a Kensington Capital Acquisition Corp. (NYSE:QS)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/quantumscape-corporation-f-k-a-kensington-capital-acquisition-corp-loss-submission-form?prid=11987&wire=1
Lead Plaintiff Deadline: March 8, 2021
Class Period: December 8, 2020 - December 31, 2020

Allegations against QS include that: (1) that the Company's purported success related to its solid-state battery power, battery life, and energy density were significantly overstated; (2) that the Company is unlikely to be able to scale its technology to the multi-layer cell necessary to power electric vehicles; and (3) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong



View source version on accesswire.com:
https://www.accesswire.com/623408/SHAREHOLDER-ALERT-BIIB-NAK-QS-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines